Upgrade to SI Premium - Free Trial

TD Cowen Reiterates Buy Rating on CVS Health (CVS)

March 13, 2026 9:26 AM
TD Cowen analyst Charles Rhyee reiterated a Buy rating and $105.00 price target on CVS Health (NYSE: CVS).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments